← Eichor
Condition: Pneumonia Bacterial Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Pneumonia Bacterial

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
Phase N/A · 1 location(s) · University of Oxford · NCT05571735A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia
Phase 2 · 1 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT06841731Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Caspofungin for Pneumocystis Pneumonia in PLWHIV.
Phase N/A · 1 location(s) · Instituto Nacional de Enfermedades Respiratorias · NCT06691321Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients with Ventilator Associated-pneumonia
Phase 3 · 1 location(s) · University Hospital, Toulouse · NCT03581370ILD-SARDs Registry and Biorepository
Phase N/A · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT05007340Hospital at Home for Elderly Acute Ill Patients
NA · 3 location(s) · Defactum, Central Denmark Region · NCT05360914Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammat
Phase 4 · 1 location(s) · Tongji Hospital · NCT06499233Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
Phase 4 · 3 location(s) · Rambam Health Care Campus · NCT05922124Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults
Phase 2 · 6 location(s) · Mundipharma Research Limited · NCT05835479Fosfomycin I.v. for Treatment of Severely Infected Patients
Phase N/A · 50 location(s) · Infectopharm Arzneimittel GmbH · NCT02979951Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia
Phase 1 · 1 location(s) · MicrobiotiX Co., Ltd · NCT07492771Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score
Phase N/A · 1 location(s) · Azienda Ospedaliero-Universitaria Careggi · NCT07681583A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacte
Phase N/A · 12 location(s) · Innoviva Specialty Therapeutics · NCT06746883Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis
Phase N/A · 1 location(s) · Sichuan Provincial People's Hospital · NCT06491966Emergency PWAS in Respiratory Infectious Disease
Phase N/A · 1 location(s) · The University of Hong Kong · NCT05336851A Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bact
NA · 1 location(s) · Henan University of Traditional Chinese Medicine · NCT07206745Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumo
Phase N/A · 1 location(s) · Fujian Medical University Union Hospital · NCT07086391A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex
Phase 2 · 6 location(s) · Omnix Medical Ltd · NCT06087536Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients
Phase N/A · 1 location(s) · Centre Hospitalier de Saint-Denis · NCT07052604FBS-ASaP: Fibrobronchoscopy in ASpiration Pneumonia in the Emergency Department
Phase N/A · 1 location(s) · Azienda Ospedaliero-Universitaria Careggi · NCT06511583Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis
Phase N/A · 1 location(s) · University of Ulm · NCT03044223BALance: ARDS Deconvolution by Bronchoalveolar Lavage Multiomics and Radiomics
Phase N/A · 1 location(s) · Medical University of Vienna · NCT07633366A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP
Phase 3 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07327619A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Pat
Phase N/A · 1 location(s) · TTY Biopharm · NCT06966284Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients W
Phase 3 · 1 location(s) · BioVersys SAS · NCT07326540Introduction of Polymerase Chain Reaction (PCR) in Microbiology and Parasitology
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07269314Combination vs. Monotherapy for Stenotrophomonas Maltophilia Infections
Phase N/A · 1 location(s) · Instituto de Investigación Sanitaria Gregorio Marañón · NCT07593547Lebanese Interhospital Pneumococcal Surveillance Program
Phase N/A · 1 location(s) · American University of Beirut Medical Center · NCT00901602
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.